Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Breast Neoplasms 50Triple Negative Breast Neoplasms 7Rectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Carcinoma, Intraductal, Noninfiltrating 6Lung Neoplasms 5Adenocarcinoma of Lung 5Breast Carcinoma In Situ 3Pancreatic Neoplasms 2Unilateral Breast Neoplasms 1Transsexualism 1Recurrence 1Piebaldism 1Neoplasm Micrometastasis 1Lymphedema 1Inflammatory Breast Neoplasms 1Gynecomastia 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1Chordoma 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Carcinoma, Ductal 1Breast Cancer Female 1Anisomastia 1Anatomic Stage IV Breast Cancer AJCC v8 1Anatomic Stage II Breast Cancer AJCC v8 1Amenorrhea 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

Imatinib Mesylate 3masitinib 2regorafenib 1ponatinib 1nilotinib 1envafolimab 1Mastectomy, Segmental 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Piebaldism × Mastectomy, Segmental × Clear all
NCT05970900 2023-08-01

PIRKER

Fujian Medical University Union Hospital

Phase 3 Not yet recruiting
23 enrolled
GastrointestinalSarcoma

Piebaldism, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡